Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Stratifin (SFN) (N-Term) Peptide

SFN Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5512711

Aperçu rapide pour Stratifin (SFN) (N-Term) Peptide (ABIN5512711)

Antigène

14-3-3 sigma/SFN (SFN) (Stratifin (SFN))

Origine

Humain

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Séquence

    IEQKSNEEGS EEKGPEVREY REKVETELQG VCDTVLGLLD SHLIKEAGDA

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-SFN Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    14-3-3 sigma/SFN (SFN) (Stratifin (SFN))

    Sujet

    SFN is a p53-regulated inhibitor of G2/M progression. It is an adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. It binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner. When bound to KRT17, regulates protein synthesis and epithelial cell growth by stimulating Akt/mTOR pathway. It may also regulate MDM2 autoubiquitination and degradation and thereby activate p53/TP53.

    Alias Symbols: SFN,HME1,

    Protein Size: 248

    ID gène

    2810

    NCBI Accession

    NP_006133

    UniProt

    P31947
Vous êtes ici:
Chat with us!